These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 33907747)
1. Human Taste Cells Express ACE2: a Portal for SARS-CoV-2 Infection. Doyle ME; Appleton A; Liu QR; Yao Q; Mazucanti CH; Egan JM bioRxiv; 2021 Apr; ():. PubMed ID: 33907747 [TBL] [Abstract][Full Text] [Related]
2. Human Type II Taste Cells Express Angiotensin-Converting Enzyme 2 and Are Infected by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Doyle ME; Appleton A; Liu QR; Yao Q; Mazucanti CH; Egan JM Am J Pathol; 2021 Sep; 191(9):1511-1519. PubMed ID: 34102107 [TBL] [Abstract][Full Text] [Related]
3. Relationship between ENaC Regulators and SARS-CoV-2 Virus Receptor (ACE2) Expression in Cultured Adult Human Fungiform (HBO) Taste Cells. Ozdener MH; Mahavadi S; Mummalaneni S; Lyall V Nutrients; 2022 Jun; 14(13):. PubMed ID: 35807883 [TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Receptor Wang Z; Zhou J; Marshall B; Rekaya R; Ye K; Liu HX ACS Pharmacol Transl Sci; 2020 Aug; 3(4):749-758. PubMed ID: 32821883 [TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 recombinant proteins-induced degeneration of taste buds in rat circumvallate papillae. Yamamoto T; Koyama Y; Imai Y; Sawada E; Kishimoto N; Seo K J Dent Sci; 2022 Jul; 17(3):1450-1453. PubMed ID: 35371412 [TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45 Ratajczak MZ; Bujko K; Ciechanowicz A; Sielatycka K; Cymer M; Marlicz W; Kucia M Stem Cell Rev Rep; 2021 Feb; 17(1):266-277. PubMed ID: 32691370 [TBL] [Abstract][Full Text] [Related]
7. Review of taste and taste disturbance in COVID-19 patients. Guan G; Rich AM; Polonowita A; Mei L N Z Med J; 2022 Feb; 135(1549):81-91. PubMed ID: 35728142 [TBL] [Abstract][Full Text] [Related]
8. Morphological and Immunopathological Aspects of Lingual Tissues in COVID-19. Henin D; Pellegrini G; Carmagnola D; Lanza Attisano GC; Lopez G; Ferrero S; Amendola A; De Angelis D; Tanzi E; Dellavia C Cells; 2022 Apr; 11(7):. PubMed ID: 35406811 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration. Yang Q; Hughes TA; Kelkar A; Yu X; Cheng K; Park S; Huang WC; Lovell JF; Neelamegham S Elife; 2020 Oct; 9():. PubMed ID: 33103998 [TBL] [Abstract][Full Text] [Related]
10. Variations in Cell Surface ACE2 Levels Alter Direct Binding of SARS-CoV-2 Spike Protein and Viral Infectivity: Implications for Measuring Spike Protein Interactions with Animal ACE2 Orthologs. Kazemi S; López-Muñoz AD; Hollý J; Jin L; Yewdell JW; Dolan BP J Virol; 2022 Sep; 96(17):e0025622. PubMed ID: 36000847 [TBL] [Abstract][Full Text] [Related]
11. Debulking SARS-CoV-2 in saliva using angiotensin converting enzyme 2 in chewing gum to decrease oral virus transmission and infection. Daniell H; Nair SK; Esmaeili N; Wakade G; Shahid N; Ganesan PK; Islam MR; Shepley-McTaggart A; Feng S; Gary EN; Ali AR; Nuth M; Cruz SN; Graham-Wooten J; Streatfield SJ; Montoya-Lopez R; Kaznica P; Mawson M; Green BJ; Ricciardi R; Milone M; Harty RN; Wang P; Weiner DB; Margulies KB; Collman RG Mol Ther; 2022 May; 30(5):1966-1978. PubMed ID: 34774754 [TBL] [Abstract][Full Text] [Related]
12. Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2-ACE2 Receptor Interactions. Day CJ; Bailly B; Guillon P; Dirr L; Jen FE; Spillings BL; Mak J; von Itzstein M; Haselhorst T; Jennings MP mBio; 2021 Mar; 12(2):. PubMed ID: 33785634 [TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy. Datta PK; Liu F; Fischer T; Rappaport J; Qin X Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005 [TBL] [Abstract][Full Text] [Related]
15. Human Hematopoietic Stem, Progenitor, and Immune Cells Respond Ex Vivo to SARS-CoV-2 Spike Protein. Ropa J; Cooper S; Capitano ML; Van't Hof W; Broxmeyer HE Stem Cell Rev Rep; 2021 Feb; 17(1):253-265. PubMed ID: 33089452 [TBL] [Abstract][Full Text] [Related]
16. Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding. Byrnes JR; Zhou XX; Lui I; Elledge SK; Glasgow JE; Lim SA; Loudermilk RP; Chiu CY; Wang TT; Wilson MR; Leung KK; Wells JA mSphere; 2020 Sep; 5(5):. PubMed ID: 32938700 [TBL] [Abstract][Full Text] [Related]
17. Variations in cell-surface ACE2 levels alter direct binding of SARS-CoV-2 Spike protein and viral infectivity: Implications for measuring Spike protein interactions with animal ACE2 orthologs. Kazemi S; López-Muñoz AD; Hollý J; Jin L; Yewdell JW; Dolan BP bioRxiv; 2021 Oct; ():. PubMed ID: 34729559 [TBL] [Abstract][Full Text] [Related]
18. Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells. Okoloko O; Vanderwall ER; Rich LM; White MP; Reeves SR; Harrington WE; Barrow KA; Debley JS Front Pharmacol; 2021; 12():765951. PubMed ID: 34867390 [No Abstract] [Full Text] [Related]